Skip to content
Evanesc Therapeutics logo — Evanesc Therapeutics is revolutionizing the treatment of neu...

Evanesc Therapeutics

Evanesc Therapeutics is revolutionizing the treatment of neurological diseases with their patented EvaPermea technology.

United States Canoga Park, United States 3 employees Health Care

General Information

Company Name Evanesc Therapeutics
Location United States Canoga Park, United States
Employees 3
Industries Health Care
Social

BounceWatch is an independent company data service, not affiliated with Evanesc Therapeutics. To contact Evanesc Therapeutics, visit evanesc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Evanesc Therapeutics compare?

A PDF of Evanesc Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Evanesc Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Evanesc Therapeutics

Evanesc Therapeutics is a health care startup based in the United States, aiming to transform the treatment of neurological diseases with their groundbreaking EvaPermea technology. This patented medical device utilizes low power RF electric fields to temporarily and non-invasively open the blood-brain barrier (BBB), enabling the use of existing or new drugs in treating various neurological disorders and Central Nervous System (CNS) diseases. The potential applications of EvaPermea span across conditions such as Alzheimer's and Parkinson's disease, brain cancer, and brain metastases. The innovative approach of Evanesc Therapeutics holds promise in addressing critical unmet medical needs in the field of neurological health.

Business keywords: neurological diseases, EvaPermea technology, medical device, blood-brain barrier, RF electric fields, Central Nervous System diseases, Alzheimer's disease, Parkinson's disease, brain cancer, brain metastases, non-invasive treatment, drug delivery, neurology, biomedical technology, innovation

No funding data available for Evanesc Therapeutics yet.

Evanesc Therapeutics Alternatives & Competitors

View All Alternatives
Evanesc Therapeutics vs

Pioneering breakthrough technology enabling new non-invasive diagnostics and therapeutics for CNS di...

Venture round
Biotechnology, Health Care
Evanesc Therapeutics vs

First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle n...

Non Equity Assistance
13 employees
Biotechnology, Health Care
Evanesc Therapeutics vs
Cordance Medical
Cordance Medical United States

Non-invasive therapy delivery system for central nervous system diseases

Seed
10 employees
Health Care, Health and Wellness

FAQ About Evanesc Therapeutics

Evanesc Therapeutics is revolutionizing the treatment of neurological diseases with their patented EvaPermea technology.
Evanesc Therapeutics is headquartered in Canoga Park, United States.
Evanesc Therapeutics operates in Health Care. Its work centres on neurological diseases, EvaPermea technology, medical device and blood-brain barrier.
Evanesc Therapeutics has approximately 3 employees.
Top alternatives and competitors to Evanesc Therapeutics include ICB International, Lys Therapeutics, Cordance Medical, Cerebral Therapeutics, Inc., EyeMove. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Evanesc Therapeutics and ICB International are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Evanesc Therapeutics, https://bouncewatch.com/company/evanesc-therapeutics, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout